Association of postpartum depressive symptoms and urinary incontinence. A cohort study. (March 2016)

• Record Type: Journal Article
• Authors: Fritel, Xavier; Tsegan, Yawo Edem; Pierre, Fabrice; Saurel-Cubizolles, Marie-Josèphe
• Is Part Of: European journal of obstetrics, gynecology, and reproductive biology. Volume 198(2016:Mar.)
• Page Start: 62
• Page End: 67
• Publication Date: 2016-03
• Subjects: Postnatal depression -- Antidepressant consumption -- Postpartum care -- Urinary incontinence -- Cohort study; Obstetrics -- Periodicals; Gynecology -- Periodicals; Reproductive health -- Periodicals; Gynecology -- Periodicals; Obstetrics -- Periodicals; Reproduction -- Periodicals; Obstétrique -- Périodiques; Gynécologie -- Périodiques; Reproduction -- Périodiques; Verloskunde; Gynaecologie; Voortplanting (biologie); Gynecology; Obstetrics; Reproduction; Electronic journals; Periodicals; Electronic journals; 618.05
• DOI: 10.1016/j.ejogrb.2015.12.028
• Languages: English
• ISSNs: 0301-2115

Abstract

Abstract: Objective: Our objective was to clarify whether de novo urinary incontinence (UI) in the postpartum period is associated with depressive symptoms or antidepressant drug consumption. Study design: 2002 pregnant women were recruited between 2003 and 2006 for the EDEN mother–child cohort. This analysis included 1413 women who reported no UI before pregnancy. Severity of UI was assessed by the Sandvik index. At 4 and 12 months postpartum, depressive symptoms were assessed by the Edinburgh Postpartum Depression Scale (EPDS ≥ 10 defines depressive symptoms) and consumption of antidepressant drugs was reported. Results: At 4 months postpartum, 198 women (14%) reported de novo UI; 74% ( n = 146) reported mild UI, 26% ( n = 52) moderate, and none severe; prevalence of depressive symptoms was higher in women with than without UI (22.1% vs. 15.9%, p = 0.045), and consumption of antidepressant drugs was more frequent (4.7% vs. 1.4%, p = 0.005). At 12 months postpartum, the mean (±SD) EPDS score differed between women with than without UI (7.30 ± 3.46 vs. 6.57 ± 3.72, p = 0.016) but was half that at 4 months postpartum. The incidence of new cases of depressive symptoms or antidepressant consumption at 12 months was greater with than without UI (23.8% vs. 15.3%, p = 0.012). Conclusions: Although UI is mild in most cases at 4 months postpartum, it is followed by more new cases of depressive symptoms or antidepressant consumption at 12 months.